MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 52 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,099 | -99.8% | 193 | -99.8% | 0.00% | -100.0% |
| Q2 2023 | $2,862,412 | +193.8% | 110,646 | +172.8% | 0.00% | – |
| Q1 2023 | $974,395 | -53.4% | 40,566 | -62.1% | 0.00% | -100.0% |
| Q4 2022 | $2,088,763 | +452.6% | 107,116 | +495.9% | 0.00% | – |
| Q3 2022 | $378,000 | +869.2% | 17,977 | +624.6% | 0.00% | – |
| Q4 2021 | $39,000 | +160.0% | 2,481 | +229.0% | 0.00% | – |
| Q3 2021 | $15,000 | -34.8% | 754 | -35.1% | 0.00% | – |
| Q1 2021 | $23,000 | -90.9% | 1,161 | -92.0% | 0.00% | – |
| Q4 2020 | $254,000 | -8.3% | 14,554 | +1.4% | 0.00% | – |
| Q3 2020 | $277,000 | -9.8% | 14,349 | -9.2% | 0.00% | – |
| Q2 2020 | $307,000 | +29.0% | 15,797 | -7.1% | 0.00% | – |
| Q1 2020 | $238,000 | +101.7% | 17,000 | +252.9% | 0.00% | – |
| Q4 2019 | $118,000 | +227.8% | 4,817 | +34.3% | 0.00% | – |
| Q3 2019 | $36,000 | – | 3,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |